DLB Dolby Laboratories Inc

Price (delayed)

$87.65

Market cap

$8.35B

P/E Ratio

41.74

Dividend/share

$1.11

EPS

$2.1

Enterprise value

$7.58B

Dolby Laboratories is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research ...

Highlights
The equity has grown by 4.8% YoY
The revenue has increased by 3.7% YoY
The EPS has grown by 14% year-on-year but it has declined by 8% since the previous quarter
The net income has increased by 9% year-on-year but it has declined by 8% since the previous quarter
DLB's price to earnings (P/E) is 28% higher than its 5-year quarterly average of 32.5 and 15% higher than its last 4 quarters average of 36.4
Dolby Laboratories's quick ratio has decreased by 26% YoY

Key stats

What are the main financial stats of DLB
Market
Shares outstanding
95.28M
Market cap
$8.35B
Enterprise value
$7.58B
Valuations
Price to book (P/B)
3.56
Price to sales (P/S)
6.46
EV/EBIT
34.32
EV/EBITDA
23.96
EV/Sales
5.83
Earnings
Revenue
$1.3B
EBIT
$220.98M
EBITDA
$316.49M
Free cash flow
$336.74M
Per share
EPS
$2.1
Free cash flow per share
$3.52
Book value per share
$24.62
Revenue per share
$13.57
TBVPS
$25.1
Balance sheet
Total assets
$2.98B
Total liabilities
$607.58M
Debt
$50.65M
Equity
$2.36B
Working capital
$1.07B
Liquidity
Debt to equity
0.02
Current ratio
3.52
Quick ratio
3.32
Net debt/EBITDA
-2.42
Margins
EBITDA margin
24.4%
Gross margin
88.3%
Net margin
15.4%
Operating margin
16.6%
Efficiency
Return on assets
6.9%
Return on equity
8.6%
Return on invested capital
16.8%
Return on capital employed
8.6%
Return on sales
17%
Dividend
Dividend yield
1.27%
DPS
$1.11
Payout ratio
52.9%

DLB stock price

How has the Dolby Laboratories stock price performed over time
Intraday
0.13%
1 week
1.81%
1 month
3%
1 year
18.21%
YTD
24.26%
QTD
10.59%

Financial performance

How have Dolby Laboratories's revenue and profit performed over time
Revenue
$1.3B
Gross profit
$1.15B
Operating income
$215.75M
Net income
$200.66M
Gross margin
88.3%
Net margin
15.4%
The operating margin has declined by 13% since the previous quarter
Dolby Laboratories's operating income has decreased by 12% QoQ but it has increased by 4.4% YoY
The net income has increased by 9% year-on-year but it has declined by 8% since the previous quarter
The net margin has declined by 9% since the previous quarter but it rose by 4.8% year-on-year

Growth

What is Dolby Laboratories's growth rate over time

Valuation

What is Dolby Laboratories stock price valuation
P/E
41.74
P/B
3.56
P/S
6.46
EV/EBIT
34.32
EV/EBITDA
23.96
EV/Sales
5.83
DLB's price to earnings (P/E) is 28% higher than its 5-year quarterly average of 32.5 and 15% higher than its last 4 quarters average of 36.4
The EPS has grown by 14% year-on-year but it has declined by 8% since the previous quarter
DLB's price to book (P/B) is 15% higher than its 5-year quarterly average of 3.1 and 8% higher than its last 4 quarters average of 3.3
The equity has grown by 4.8% YoY
DLB's price to sales (P/S) is 8% higher than its last 4 quarters average of 6.0 and 4% higher than its 5-year quarterly average of 6.2
The revenue has increased by 3.7% YoY

Efficiency

How efficient is Dolby Laboratories business performance
The return on sales has declined by 17% since the previous quarter
The company's return on equity rose by 16% YoY but it fell by 9% QoQ
Dolby Laboratories's return on invested capital has decreased by 15% QoQ but it has increased by 11% YoY
Dolby Laboratories's return on assets has decreased by 12% QoQ but it has increased by 10% YoY

Dividends

What is DLB's dividend history
DPS
$1.11
Dividend yield
1.27%
Payout ratio
52.9%
Recent dividends

Financial health

How did Dolby Laboratories financials performed over time
The total liabilities rose by 39% year-on-year but it has declined by 2.8% since the previous quarter
Dolby Laboratories's quick ratio has decreased by 26% YoY
The debt is 98% smaller than the equity
The equity has grown by 4.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.